Trading Signals: TGTX Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 14, 2022)(TG Therapeutics Inc)
| TGTX latest price $14.2800 (0.63%) ($14.2800 - $14.2800) on Wed. Jan. 19, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 6.4% (three month average) | RSI | 24 | Latest Price | $14.2800(0.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | TGTX declines -3.5% a day on average for past five trading days. | Weekly Trend | TGTX declines -12.1% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support TGTX advance at 0% a week (0% probability) XBI(75%) ARKG(69%) IBB(67%) ARKK(64%) IWO(61%) | Factors Impacting TGTX price | TGTX will decline at least -3.2% in a week (0% probabilities). VIXM(-47%) VXX(-38%) UUP(-27%) UNG(-7%) USO(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.2% (StdDev 6.4%) | Hourly BBV | -1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-2.48(-117.37%) | Resistance Level | $17.57 | 5 Day Moving Average | $15.05(-5.12%) | 10 Day Moving Average | $16.18(-11.74%) | 20 Day Moving Average | $17.57(-18.73%) | To recent high | -59.9% | To recent low | 0.6% | Market Cap | $1.809b | | | | TG Therapeutics, Inc. is a biopharmaceutical company, which engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1101, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in New York, NY. |